Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Cosibelimab
Trade Name
Synonyms CK-301|CK 301|TG-1501|TG1501|TG 1501
Drug Descriptions

Cosibelimab (CK-301) is a human monoclonal antibody against PD-L1 (CD274), which may block immune checkpoint, lead to anti-tumor immune response (Ann Oncol. Oct 2019, Vol 30 (Suppl_5): v177).

DrugClasses Immune Checkpoint Inhibitor 148 PD-L1/PD-1 antibody 93
CAS Registry Number 2216751-26-5
NCIT ID C151947


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Carboplatin + Cosibelimab + Pemetrexed Disodium Carboplatin Cosibelimab Pemetrexed Disodium 0 1
Cisplatin + Cosibelimab + Pemetrexed Disodium Cisplatin Cosibelimab Pemetrexed Disodium 0 1
Cosibelimab Cosibelimab 0 2

Additional content available in CKB BOOST